Renal and Cardiovascular Complications in Type 2 Diabetes Mellitus: Role of Blood Glucose, Renin-Angiotensin System and Blood Pressure
Robert W. Schrier, MD (Denver CO, USA)
Albuminuria, proteinuria and renal insufficiency as cardiovascular risk factors
K.U. Eckardt (Erlangen, Germany)
Nephroprotection by intensified blood pressure control: Final results of the ESCAPE-trial
E. Wühl (Heidelberg, Germany)
Primary aldosteronism causes renal dysfunction
Examination of kidney function before and after surgery
J. Saito (Yokohama, Japan)
Influence Factors for Serum Creatinine to Measure GFR Endocrine hypertension: pheochromocytoma, diabetes, obesity, thyroid disorders
L. Landsberg (Chicago IL, USA)
Primary aldosteronism
G.P. Rossi (Padova, Italy)
High plasma aldosterone and low plasma renin predict blood pressure increase and hypertension in middle-aged caucasian populations
J. Ménard (Paris, France)
A clinical prediction rule for unilateral primary aldosteronism in a hypertension unit
O. Steichen (Paris, France)
Primary aldosteronism in patients with intolerance to spironolactone: usefulness of eplerenone
J.A. Garcia-Donaire (Madrid, Spain)
Sex and gender differences in hypertension
V. Regitz-Zagrosek (Berlin, Germany)
Target organ damage in hypertension: influence of gender – an epidemiological perspective
I. Ferreira (Maastricht, Netherlands)
Renin causes cyclic GMP-dependent relaxation of rat renal arteries
S. Becker (London, United Kingdom)
Sex different effect of AT2 receptor signaling on brain ischemic injury and cognitive function
A. Sakata (Tohon, Japan)
Systematic search for sex-specific genomic determinants of hypertension- related traits in French Canadians
P. Hamet (Montreal, Canada)
Treatment of hypertension in children
W. Rascher (Erlangen, Germany)
Factors related to the development of essential hypertension in adolescents
E. Lurbe (Valencia, Spain)
Hypertension among children and adolescents in China
J. Mi (Beijing, China)
Masked and white coat hypertension in children and adolescents detected by home blood pressure monitoring: The Arsakeion School study
G. Stergiou (Athens, Greece)
Reduced kidney size correlates with increased salt sensitivity in low birth weight children
G. Simonetti (Bern, Switzerland)
Stroke prevention and treatment - Epidemiology and primary prevention
R. Cifkova (Prague, Czech Republic)
Stroke, Acute treatment and secondary prevention
B. Carlberg (Umea, Sweden)
Control of Hypertension & Hypotension Immediately Post-Stroke Pilot Trial
J. Potter (Norwich, United Kingdom)
The beta-lactam antibiotic ceftriaxon stimulates glutamate transporter activity, induces neurotrophin expression, and dramatically reduces acute mortality in an animal model of stroke
U.M. Steckelings (Berlin, Germany)
Trends in Incidence of stroke and risk factors in Okinawa, Japan
C. Sugama (Nishihara-cho,Okinawa, Japan)
Evaluation of cardiac structure and function in arterial hypertension: role of echocardiography
C. Cuspidi (Milan, Italy)
Imaging myocardial ischaemia in hypertension
P. Camici (London, United Kingdom)
Electrocardiogram as screening test for left ventricular hypertrophy
O. Steichen (Paris, France)
A novel method to directly derive Central Aortic Systolic Pressure (CASP) from the radial artery pressure waveform – Validation with data from the CAFE study
B. Williams (Leicester, United Kingdom)
Mitral E wave deceleration time-to-peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment: the LIFE echo-substudy
M. Chinali (Napoli, Italy)
Early predictors of renal protection with antihypertensive therapy
G. Kimura (Nagoya, Japan)
Hypertension - Post-renal transplantation
E. Burgess (Calgary, Canada)
Albuminuria predicts graft survival after kidney transplantation – Effect of RAAS blockade
U. Hillebrand (Münster, Germany)
Early pulse pressure and low grade proteinuria as long-term risk factors for new-onset diabetes mellitus after kidney transplantation
J.M. Halimi (Tours, France)
Reduced basal renal function and altered response to Ang II following fetal uninephrectomy in male sheep
R. Singh (Melbourne, Australia)
When to look for Genetic Influences in Hypertensives?
A. Dominiczak (Glasgow, United Kingdom)
Risk Factor Control in Hypertension: Should we give Antiplatelet Drugs in all Hypertensives? Should we give Statins to all Hypertensives?
G. Mc Innes (Glasgow, United Kingdom)
Do we need new Antihypertensive Drugs?
P. Van Zwieten (Amsterdam, Netherlands)
Hyperaldosteronism: Should we check on it in all hypertensive patients? Arguments Pro
G. Paolo Rossi (Padova, Italy)
Diagnosis and Management of Hyperaldosteronism
A. Heagerty (Manchester, United Kingdom)
Angioplasty for atherosclerotic renovascular disease
P.F. Plouin (Paris, France)
Pheochromocytoma
G. Grassi (Milan, Italy)
Treatment of HT in General and Special Conditions About a diffucult case
S. Erdine (Istanbul, Turkey)
Masked hypertension (Isolated Ambulatory Hypertension)
D. Clement (Leuven, Belgium)
Hypertension in Women Should they be treated differently?
R. Cifkova (Prague, Czech Republic)
Vascular Damage: From Angiogenesis to hypertension
Peter Carmeliet (Leuven, Belgium)
(Note: This lecture is not available as webcast)
Renin-, prorenin receptors and tissue damage
Jan Danser (Rotterdam, Netherlands)
Outcome trials and antihypertensive treatment: importance and limitations
Giuseppe Mancia (Milan, Italy)
MicroRNAs and the tell-tale heart
K. Chien (Boston, MA, USA)
(Note: This lecture is not available as webcast)
Blood pressure and vascular disease: a global perspective
S. MacMahon (Sydney, Australia)
Cardiovascular disease continuum at 15+ years: lessons learned & future directions
V. Dzau (Durham NC, United States of America)
Global burden of cardiovascular disease: a major public health problem
R. Horton (London, United Kingdom)
Nuclear receptors, inflammation and cardiovascular disease
C. K. Glass (La Jolla CA, United States of America)
Stem cells in cardiovascular disease and treatment
A. Zeiher (Frankfurt am Main, Germany) (Replaced by: Birgit Assmus)
Blood pressure lowering and acute stroke
S. Strandgaard (Herlev, Denmark)
ACCOMPLISH: early lessons from the blood pressure and outcomes data
M. Weber (New York NY, United States of America)
Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension
K. Jamerson (Ann Arbor, United States of America)
A factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
J. Chalmers (Sydney, Australia)
A vaccine for hypertension
J. Menard (Paris, France)
Angiotensin-immunization study
J. Nussberger (Lausanne, Switzerland)
Blood pressure analyses from 25595 patients (from 25620 randomised) during the ONTARGET trial: reflections on current guidelines
P. Sleight (Oxford, United Kingdom)
ONTARGET: results in people with CKD stage 3-4 and at high CV risk
R.E. Schmieder (Erlangen, Germany)
Inhibition of renin angiotensin system by mono vs dual therapy: insights from the ONTARGET trial
K. Teo (Hamilton, Ontario, Canada)
Angiotensin II receptor blockers and risk of myocardial infarction:a meta-analysis of randomised clinical trials updated until May 15, 2008
Giuliano Tocci (Rome, Italy)
Long-term risk of developing impaired fasting glucose and diabetes in white coat and masked hypertension: data from the PAMELA study
G. Grassi (Milan, Italy)
OSCAR: an Observational Study of Cognitive function Associated with the toleRability of teveten- Australian Arm
M. Nakhla (Sydney, Australia)
Platelet cGMP; specific marker of in vivo NO release/activity
K. Bendjama (Bresso, Italy)
Systolic blood pressure is all that matters
P. Sever (London, United Kingdom)
Manganese-superoxide dismutase and mitochondrial aldehyde dehydrogenase deficiency potentiate aging-associated vascular dysfunction, mitochondrial oxidative stress and mtDNA strand breaks
A. Daiber (Mainz, Germany)
Progression of hypertensive chronic kidney disease (CKD): longterm results from the African-American Study of Kidney disease and hypertension (AASK)
L. Appel (Baltimore, United States of America)
Enhanced vascular reactivity to cold pressor test in African normotensive subjects
D. Lemogoum (Douala, Cameroon)
Alpha-adrenergic blockade titrated by self-measured BP lowered microalbuminuria in patients with morning hypertension The JMS – 1 Study
K. Kario (Tochigi, Japan)